(Last updated : 2024-03-26 17:52:02)
  中島 亜矢子
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Internal Medicine, Division of Rheumatology
   Position  
■ Published papers
1. Original article  Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort 2024/02/26
2. Original article  Trends in Risks of Malignancies in Japanese Patients with Rheumatoid Arthritis: Analyses from a 14-year Observation of the IORRA Cohort. 2022/08/03
3. Original article  Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort. 2022/07/01
4. Original article  Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids. 2022/04/18
5. Original article  Geographic variations in rheumatoid arthritis treatment in Japan: A nationwide retrospective study using the national database of health insurance claims and specific health checkups of Japan. 2022/01
Display all(47)
■ Academic conference presentation
1. Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort  2020/08/04
2. The minimally important difference in the European quality of life-five dimensions(EQ-5D) in patients with rheumatoid arthritis based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort.  2014/11/16
3. Difficulty in Maintainning full physical function for 10 years in patients with early rheumatoid arthritis in daily clinical practice.Analysis of the IORRA cohort.  2014/06/13
4. Treatment for Rheumatoid arthritis patients after a lymphoproliferative disorder.  2014/06/13
5. Functional Disability and Quality Of Life Are More Likely Improved In Patients With Rheumatoid Arthritis Who Achieved The New ACR/EULAR Remission Criteria Compared To DAS28 Remission In Daily Practice  2013/10
Display all(19)